Global Drugs for Schistosomiasis Market Study 2016-2026, by Segment (Praziquantel, Oxamniquine, … …), by Market (S. haematobium, S. mansoni, … …), by Company (Merck, Shin Poong, … …)

Published by 99Strategy on 17th November 2019 | Ref: 1463717 | This Product Is In Stock

$1800 | Single User
$3600 | Site License
$3600 | Enterprise License
$1800 | Single User
$3600 | Site License
$3600 | Enterprise License

Introduction

Summary

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

The global Drugs for Schistosomiasis market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Praziquantel

Oxamniquine

Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):

S. haematobium

S. mansoni

S. japonicum

S. mekongi

S. intercalatum

Company Coverage (Sales data, Main Products & Services etc.):

Merck

Shin Poong

Bayer

EIPICO

Chandra Bhagat Pharma

Taj Pharmaceuticals

Major Region Market

North America

Europe

Asia-Pacific

South America

Middle East & Africa

Table of Contents

Table of Content

1 Industry Overview

1.1 Drugs for Schistosomiasis Industry

1.2 Market Segment

1.3 Price & Cost Overview

2 Drugs for Schistosomiasis Market by Type

2.1 By Type

2.2 Market Size by Type

2.3 Market Forecast by Type

3 Global Market Demand

3.1 Segment Overview

3.2 Market Size by Demand

3.3 Market Forecast by Demand

4 Major Region Market

4.1 Global Market Overview

4.2 Major Region

5 Major Companies List

5.1 Merck (Company Profile, Sales Data etc.)

5.2 Shin Poong (Company Profile, Sales Data etc.)

5.3 Bayer (Company Profile, Sales Data etc.)

5.4 EIPICO (Company Profile, Sales Data etc.)

5.5 Chandra Bhagat Pharma (Company Profile, Sales Data etc.)

5.6 Taj Pharmaceuticals (Company Profile, Sales Data etc.)

6 Conclusion

Additional Details

Publisher

99Strategy

Publisher Information

Reference

1463717 | 99SGL180Lif201909000024381

Number of Pages

47

Report Format

PDF

Related Reports

Title
Date Published
Price From
Link

Published by BuddeComm
15-02-2017

$3,950 USD

This report is published by 99Strategy

99Strategy is a well-known independent third party market research consulting company in China.

We are committed to providing professional solutions for corporate strategic decision-making, we operate three business department of market research, custom survey and Investment & financing, mainly covering research report, market survey, competitive survey, market channel investigation, market entry research, consumer research, global market research, business Plan, project feasibility study, PPP project consulting, enterprise IPO and equity investment research, special market solutions, industry plan consulting, company strategic planning, sales consulting, management consulting and other services.

Download Free Report Summary PDF

Global Drugs for Schistosomiasis Market Study 2016-2026, by Segment (Praziquantel, Oxamniquine, … …), by Market (S. haematobium, S. mansoni, … …), by Company (Merck, Shin Poong, … …) | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.